Zobrazeno 1 - 10
of 346
pro vyhledávání: '"Kuessner, D"'
Autor:
Geissbühler Y; Novartis Pharma AG, Basel, Switzerland. Electronic address: yvonne.geissbuehler@novartis.com., Johnson JC; Optum, Eden Prairie, Minnesota, United States., Gharbi H; Novartis Pharma AG, Basel, Switzerland., Aubrun E; Novartis Pharma AG, Basel, Switzerland., Kuessner D; Novartis Pharma AG, Basel, Switzerland., Smolskis JM; Optum, Eden Prairie, Minnesota, United States., Barcelos G; Novartis Pharma AG, Basel, Switzerland; Pfizer AG, Zurich, Switzerland., Prieto L; Novartis Pharma AG, Basel, Switzerland.
Publikováno v:
Transplantation proceedings [Transplant Proc] 2024 Jul-Aug; Vol. 56 (6), pp. 1290-1299. Date of Electronic Publication: 2024 Jul 26.
Autor:
Wratten S; Patient-Centered Outcomes, Adelphi Values, Bollington, UK., Abetz-Webb L; Patient-Centered Outcomes, Adelphi Values, Bollington, UK., Arenson E; Patient-Centered Outcomes, Adelphi Values, Bollington, UK., Griffiths P; Patient-Centered Outcomes, Adelphi Values, Bollington, UK., Bowman S; Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Hueber W; Department of Immunology, Novartis Pharma, Basel, Switzerland., Ndife B; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Kuessner D; Department of Immunology, Novartis Pharma, Basel, Switzerland., Goswami P; Department of Immunology, Novartis Pharma, Basel, Switzerland pushpendra.goswami@novartis.com.
Publikováno v:
RMD open [RMD Open] 2023 Mar; Vol. 9 (1).
Autor:
Rincón Villar, María1 (AUTHOR) mrinconv@saludcastillayleon.es, Alonso-Sardón, Montserrat2 (AUTHOR) sardonm@usal.es, Alvarez-Artero, Elisa1 (AUTHOR) e.alvarez.artero@gmail.com, Rodríguez Alonso, Beatriz3 (AUTHOR) beamedicina@gmail.com, López-Bernús, Amparo4 (AUTHOR) alopezb@saludcastillayleon.es, Romero-Alegría, Ángela3 (AUTHOR) aralegria@yahoo.es, Pardo-Lledías, Javier5 (AUTHOR) javipard2@hotmail.com, Belhassen-García, Moncef4 (AUTHOR) e.alvarez.artero@gmail.com
Publikováno v:
Journal of Fungi. Nov2024, Vol. 10 Issue 11, p733. 17p.
Autor:
Zborayova, Katarina1 (AUTHOR) Katarina.Zborayova@regionvasterbotten.se, Barrenäs, Marie-Louise1 (AUTHOR), Granåsen, Gabriel2 (AUTHOR), Kerber, Kevin3 (AUTHOR), Salzer, Jonatan4 (AUTHOR)
Publikováno v:
BMC Public Health. 9/27/2024, Vol. 24 Issue 1, p1-10. 10p.
Autor:
Heike, Benecke, Herminio, Pérez-Garrigues, Dinsuhaimi, Bin Sidek, Ingrida, Uloziene, Kuessner, D, Eric, Sondag, Ad, Theeuwes, Algarra J, Marco
Publikováno v:
The international tinnitus journal. 16(1)
This was a 3-month multicentre, open-label post-marketing surveillance study of betahistine (24 mg b.i.d. or 16 mg t.i.d.) in patients with vertigo of peripheral vestibular origin. Study endpoints comprised on-treatment changes in the Dizziness Handi
Autor:
Floros L; Covance Market Access, London, UK.; Covance Market Access, London, UK., Kuessner D; Basilea Pharmaceutica International Ltd, Basel, Switzerland. Daniel.kuessner@basilea.com., Posthumus J; Basilea Pharmaceutica International Ltd, Basel, Switzerland., Bagshaw E; Covance Market Access, London, UK.; Covance Market Access, London, UK., Sjölin J; Department of Medical Sciences, Infectious Diseases, Uppsala University, Uppsala, Sweden.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2019 Feb 11; Vol. 19 (1), pp. 134. Date of Electronic Publication: 2019 Feb 11.
Publikováno v:
In Value in Health November 2016 19(7):A417-A417
Autor:
Herbrecht R; a Département d'Oncologie et d'Hématologie , Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, University of Strasbourg , Inserm, UMR-S1113/IRFAC, Strasbourg , France., Kuessner D; b Basilea Pharmaceutica International Ltd , Basel , Switzerland., Pooley N; c PHMR , London , UK., Posthumus J; b Basilea Pharmaceutica International Ltd , Basel , Switzerland., Escrig C; b Basilea Pharmaceutica International Ltd , Basel , Switzerland.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2018 Dec; Vol. 34 (12), pp. 2187-2195. Date of Electronic Publication: 2018 Aug 17.
Autor:
Bagshaw E; Covance Market Access, London, UK., Enoch DA; Clinical Microbiology & Public Health Laboratory, Public Health England, National Infection Service, Box 236, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Blackney M; Covance Market Access, London, UK., Posthumus J; Basilea Pharmaceutica International Ltd, Basel, Switzerland., Kuessner D; Basilea Pharmaceutica International Ltd, Basel, Switzerland.
Publikováno v:
Future microbiology [Future Microbiol] 2018 Sep; Vol. 13, pp. 1283-1293. Date of Electronic Publication: 2018 Jun 18.
Publikováno v:
Current Medical Research & Opinion; Nov2007, Vol. 23 Issue 11, p2753-2761, 9p